David Kirkpatrick

May 1, 2010

US government puts $145M into anti-cancer nanotech research

I’ve done a ton of blogging on cancer fighting nanotechnology, so I’m particularly pleased to read about this government initiative. Nanotech may well be the “magic bullet” researchers have been searching for in the battle against cancer.

From the second link, the release:

New advances in science of the ultra-small promise big benefits for cancer patients

IMAGE: Gold nanoparticles, the bright structures attached to the cultured human cell in this electron microscope image, are among the ultra-small technologies that may help improve the diagnosis and treatment of…

Click here for more information.

A $145-million Federal Government effort to harness the power of nanotechnology to improve the diagnosis, treatment, and prevention of cancer is producing innovations that will radically improve care for the disease. That’s the conclusion of an update on the status of the program, called the National Cancer Institute Alliance for Nanotechnology in Cancer. It appears in ACS Nano, a monthly journal published by the American Chemical Society.

Piotr Grodzinski and colleagues note in the article that the alliance, launched in 2004, funds and coordinates research specifically intended to move knowledge about the small science out of laboratories and into hospitals and doctors offices in a big way. It builds on more than 50 years of advances in cancer care that although substantial, still leave cancer as the No. 1 cause of death in the United States and globally.

The article describes a range of advances, including some showing significant promise in clinical trials that are poised to make a big impact on cancer. They promise earlier disease diagnosis, highly targeted treatments that kill cancer cells but leave normal cells alone, fewer side effects, and improved survival, the article

###

ARTICLE FOR IMMEDIATE RELEASE “Recent Advances from the National Cancer Institute Alliance for Nanotechnology in Cancer”

DOWNLOAD FULL TEXT ARTICLE http://pubs.acs.org/stoken/presspac/presspac/full/10.1021/nn100073g

July 16, 2010

Nanotech and breast cancer

Nanotechnology is proving to be a key component in the fight against cancer and I’ve done a lot of blogging about the topic. Here’s another breakthrough on that front, this time targeting breast cancer with an arsenic nanoparticle.

From the second link, the release:

New Arsenic Nanoparticle Blocks Aggressive Breast Cancer

New technology targets cancer prevalent in young women

By Marla Paul

CHICAGO — You can teach an old drug new chemotherapy tricks. Northwestern University researchers took a drug therapy proven for blood cancers but ineffective against solid tumors, packaged it with nanotechnology and got it to combat an aggressive type of breast cancer prevalent in young women, particularly young African-American women.

That drug is arsenic trioxide, long part of the arsenal of ancient Chinese medicine and recently adopted by Western oncologists for a type of leukemia. The cancer is triple negative breast cancer, which often doesn’t respond well to traditional chemotherapy and can’t be treated by potentially life-saving targeted therapies. Women with triple negative breast cancer have a high risk of the cancer metastasizing and poor survival rates.

Prior to the new research, arsenic hadn’t been effective in solid tumors. After the drug was injected into the bloodstream, it was excreted too rapidly to work. The concentration of arsenic couldn’t be increased, because it was then too toxic.

A new arsenic nanoparticle — designed to slip undetected through the bloodstream until it arrives at the tumor and delivers its poisonous cargo — solved all that. The nanoparticle, called a nanobin, was injected into mice with triple negative breast tumors. Nanobins loaded with arsenic reduced tumor growth in mice, while the non-encapsulated arsenic had no effect on tumor growth. The arsenic nanobins blocked tumor growth by causing the cancer cells to die by a process known as apoptosis.

The nanobin consists of nanoparticulate arsenic trioxide encapsulated in a tiny fat vessel (a liposome) and coated with a second layer of a cloaking chemical that prolongs the life of the nanobin and prevents scavenger cells from seeing it. The nanobin technology limits the exposure of normal tissue to the toxic drug as it passes through the bloodstream. When the nanobin gets absorbed by the abnormal, leaky blood vessels of the tumor, the nanoparticles of arsenic are released and trapped inside the tumor cells.

“The anti-tumor effects of the arsenic nanobins against clinically aggressive triple negative breast tumors in mice are extremely encouraging,” said Vince Cryns, associate professor of medicine and an endocrinologist at Northwestern Medicine and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “There’s an urgent need to develop new therapies for poor prognosis triple negative breast cancer.”

Cryns and Tom O’Halloran, director of the Chemistry of Life Processes Institute at Northwestern, are senior authors of a paper on the research, which will be published July 15 in Clinical Cancer Research and featured on the journal cover. Richard Ahn, a student in the medical scientists training program at Northwestern, is lead author.

“Everyone said you can’t use arsenic for solid tumors,” said O’Halloran, also associate director of basic sciences at the Lurie Cancer Center. “That’s because they didn’t deliver it the right way. This new technology delivered the drug directly to the tumor, maintained its stability and shielded normal cells from the toxicity. That’s huge.”

The nanoparticle technology has great potential for other existing cancer drugs that have been shelved because they are too toxic or excreted too rapidly, Cryns noted. “We can potentially make those drugs more effective against solid tumors by increasing their delivery to the tumor and by shielding normal cells from their toxicity,” he said. “This nanotechnology platform has the potential to expand our arsenal of chemotherapy drugs to treat cancer.”

“Working with both professors O’Halloran and Cryns has enabled us to develop the nanobins and hopefully create a new platform for the effective treatment of triple negative breast cancer,” Ahn said. “Having both a basic science mentor and breast cancer mentor is ideal training for me as a future physician-scientist.”

Looking ahead, the challenge now is to refine and improve the technology. “How do we make it more toxic to cancer cells and less toxic to healthy cells?” asked Cryns, also the director of SUCCEED, a Northwestern Medicine program to improve the quality of life for breast cancer survivors.

Northwestern scientists are working on decorating the nanobins with antibodies that recognize markers on tumor cells to increase the drug’s uptake by the tumor.  They also want to put two or more drugs into the same nanobin and deliver them together to the tumor.

“Once you fine-tune this, you could use what would otherwise be a lethal or highly toxic dose of the drug, because a good deal of it will be directly released in the tumor,” O’Halloran said.

The research was supported by the National Cancer Institute-funded Northwestern University Center of Cancer Nanotechnology Excellence. Northwestern has one of seven such centers in the United States.

(Northwestern Medicine is comprised of Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital.)

Marla Paul is the health sciences editor

Here’s PhysOrg’s coverage of this story.

April 21, 2010

More cancer-fighting nanotech

Filed under: Science, Technology — Tags: , , , , , , — David Kirkpatrick @ 1:26 am

Research has found carbon nanotubes can help the body’s immune system fight cancer. Hit this link for all my cancer-related nanotechnology blogging.

From the first link:

Carbon nanotubes boost cancer-fighting cells

New Haven, Conn.—Yale University engineers have found that the defects in carbon nanotubes cause T cell antigens to cluster in the blood and stimulate the body’s natural immune response. Their findings, which appear as the cover article of the April 20 issue of the journal Langmuir, could improve current adoptive immunotherapy, a treatment used to boost the body’s ability to fight cancer.

Adoptive immunotherapy involves extracting a patient’s blood so that the number of naturally occurring T cells (a type of white blood cell) can reproduce more effectively in the laboratory. Although the body produces its own tumor-fighting T cells, they are often suppressed by the tumor and are too few to be effective. Scientists boost the production of T cells outside the body using different substances that encourage T cell antigens to cluster in high concentrations. The better these substances are at clustering T cell antigens, the greater the immune cell proliferation. Once enough T cells are produced, the blood is transferred back into the patient’s body.

The Yale team had previously reported the unexpected effect that carbon nanotubes had on T cell production. They found that the antigens, when presented on the surface of the nanotubes, stimulated T cell response far more effectively than coating other substrates such as polystyrene in the antigens, even though the total amount of antigens used remained the same.

Now they have discovered the reason behind the increased stimulation. They found that the antigens cluster in high concentrations around the tiny defects found in the carbon nanotubes.

“Carbon nanotube bundles resemble a lymph node microenvironment, which has a labyrinth sort of geometry,” said Tarek Fahmy, associate professor of chemical engineering and biomedical engineering at Yale and senior author of the paper. “The nanotube bundles seem to mimic the physiology and adsorb more antigens, promoting a greater immunological response.”

Current adoptive immunotherapy takes weeks to produce enough T cells, but lab tests showed that the nanotubes produced the same T cell concentration in just one-third the time, Fahmy said.

Carbon nanotubes can cause problems, such as an embolism, when used in the body. But this isn’t the case when they are used in blood that has been extracted from the patient, Fahmy said. Next, the team will work on a way to effectively remove the carbon nanotubes from the blood before it is returned to the patient.

“We think this is a really interesting use of carbon nanotubes. It’s a way to exploit the unique properties of this material for biological application in a safe way.”

###

Other authors of the paper include lead author Tarek Fadel, Michael Look, Peter Staffier, Gary Haller and Lisa Pfefferle, all of the Yale School of Engineering & Applied Science.

March 19, 2010

More news on laser-heated nanoparticles and cancer

Filed under: Science — Tags: , , , , , , , — David Kirkpatrick @ 12:53 am

There’s been a lot of blog-worthy news on cancer research and nanotech lately, particularly on heating nanoparticles with low-intensity lasers to zap cancer cells. I first blogged on this tech a couple of years ago, but lately a number of institutions have released different research results on the process so I’m guessing it is really getting somewhere. This amount of news release activity makes me wonder if this is getting close to actually treating people. This latest release — the third this month — is from the University of Florida. This particular laser-excited nanoparticle tech does go beyond medical usage

The release:

Engineers: Weak laser can ignite nanoparticles, with exciting possibilities

GAINESVILLE, Fla. — University of Florida engineering researchers have found they can ignite certain nanoparticles using a low-power laser, a development they say opens the door to a wave of new technologies in health care, computing and automotive design.

A paper about the research appears in this week’s advance online edition of Nature Nanotechnology.

Vijay Krishna, Nathanael Stevens, Ben Koopman and Brij Moudgil say they used lasers not much more intense than those found in laser pointers to light up, heat or ignite manufactured carbon molecules, known as fullerenes, whose soccer-ball-like shapes had been distorted in certain ways. They said the discovery suggests a score of important new applications for these so-called “functionalized fullerenes” molecules already being developed for a broad range of industries and commercial and medical products.

“The beauty of this is that it only requires a very low intensity laser,” said Moudgil, professor of materials science and engineering and director of the engineering college’s Particle Engineering Research Center, where the research was conducted.

The researchers used lasers with power in the range of 500 milliwatts. Though weak by laser standards, the researchers believe the lasers have enough energy to initiate the uncoiling or unraveling of the modified or functionalized fullerenes. That process, they believe, rapidly releases the energy stored when the molecules are formed into their unusual shapes, causing light, heat or burning under different conditions.

The Nature Nanotechnology paper says the researchers tested the technique in three possible applications.

In the first, they infused cancer cells in a laboratory with a variety of functionalized fullerenes known to be biologically safe called polyhydroxy fullerenes. They then used the laser to heat the fullerenes, destroying the cancer cells from within.

“It caused stress in the cells, and then after 10 seconds we just see the cells pop,” said Krishna, a postdoctoral associate in the Particle Engineering Research Center.

He said the finding suggests doctors could dose patients with the polyhdroxy fullerenes, identify the location of cancers, then treat them using low-power lasers, leaving other tissues unharmed. Another application would be to image the locations of tumors or other areas of interest in the body using the fullerenes’ capability to light up.

The paper also reports the researchers used fullerenes to ignite a small explosive charge. The weak laser contained far less energy than standard electrical explosive initiators, the researchers said, yet still ignited a type of functionalized fullerenes called carboxy fullerenes. That event in turn ignited comparatively powerful explosives used in traditional blasting caps.

Mining, tunneling or demolition crews currently run electrical lines to explosives, a time-consuming and expensive process for distant explosives. The experiment suggests crews could use blasting caps armed with the fullerenes and simply point a laser to set them off.

“Traditional bursting caps require a lot of energy to ignite — they use a hot tungsten filament,” said Nathanael Stevens, a postdoctoral associate in the Particle Engineering Research Center. “So, it is interesting that we can do it with just a low-powered laser.”

The researchers coated paper with polyhyroxy fullerenes, then used an ultrahigh resolution laser to write a miniature version of the letters “UF.” The demonstration suggests the technique could be used for many applications that require extremely minute, precise, lithography. Moudgil said the researchers had developed one promising application involving creating the intricate patterns on computer chips.

Although not discussed in the paper, other potential applications include infusing the fullerenes in gasoline, then igniting them with lasers rather than traditional sparkplugs in car engines, Moudgil said. Because the process is likely to burn more of the gasoline entering the cylinders, it could make cars more efficient and less polluting.

The researchers have identified more than a dozen potential applications and applied for several patents. This week’s Nature Nanotechnology paper is the first scientific publication on the discovery and the new technique.

-30-

March 13, 2010

More gold nanotech cancer research

I’ve done a lot of blogging on cancer and nanotech and I’ve covered this exact use of gold nanoparticles to destroy tumors. This is new research on the same tech, and this amount of news on one cancer-fighting technique is good medical news. Earlier this week I covered this topic on research from Cornell. Today’s news comes from Washington University in St. Louis.

From the final link, the release:

A golden bullet for cancer

Nanoparticles provide a targeted version of photothermal therapy for cancer

IMAGE: Infrared images made while tumors were irradiated with a laser show that in nanocage-injected mice (left), the surface of the tumor quickly became hot enough to kill cells. In…

Click here for more information.

In a lecture he delivered in 1906, the German physician Paul Ehrlich coined the term Zuberkugel, or “magic bullet,” as shorthand for a highly targeted medical treatment.

Magic bullets, also called silver bullets, because of the folkloric belief that only silver bullets can kill supernatural creatures, remain the goal of drug development efforts today.

A team of scientists at Washington University in St. Louis is currently working on a magic bullet for cancer, a disease whose treatments are notoriously indiscriminate and nonspecific. But their bullets are gold rather than silver. Literally.

The gold bullets are gold nanocages that, when injected, selectively accumulate in tumors. When the tumors are later bathed in laser light, the surrounding tissue is barely warmed, but the nanocages convert light to heat, killing the malignant cells.

In an article just published in the journal Small, the team describes the successful photothermal treatment of tumors in mice.

IMAGE: The color of a suspension of nanocages depends on the thickness of the cages’ walls and the size of pores in those walls. Like their color, their ability to absorb…

Click here for more information.

The team includes Younan Xia, Ph.D., the James M. McKelvey Professor of Biomedical Engineering in the School of Engineering and Applied Science, Michael J. Welch, Ph.D., professor of radiology and developmental biology in the School of Medicine, Jingyi Chen, Ph.D., research assistant professor of biomedical engineering and Charles Glaus, Ph.D., a postdoctoral research associate in the Department of Radiology.

“We saw significant changes in tumor metabolism and histology,” says Welch, “which is remarkable given that the work was exploratory, the laser ‘dose’ had not been maximized, and the tumors were ‘passively’ rather than ‘actively’ targeted.”

Why the nanocages get hot

The nanocages themselves are harmless. “Gold salts and gold colloids have been used to treat arthritis for more than 100 years,” says Welch. “People know what gold does in the body and it’s inert, so we hope this is going to be a nontoxic approach.”

“The key to photothermal therapy,” says Xia, “is the cages’ ability to efficiently absorb light and convert it to heat. ”

Suspensions of the gold nanocages, which are roughly the same size as a virus particle, are not always yellow, as one would expect, but instead can be any color in the rainbow.

They are colored by something called a surface plasmon resonance. Some of the electrons in the gold are not anchored to individual atoms but instead form a free-floating electron gas, Xia explains. Light falling on these electrons can drive them to oscillate as one. This collective oscillation, the surface plasmon, picks a particular wavelength, or color, out of the incident light, and this determines the color we see.

IMAGE: Gold nanocages (right) are hollow boxes made by precipitating gold on silver nanocubes (left). The silver simultaneously erodes from within the cube, entering solution through pores that open in the…

Click here for more information.

Medieval artisans made ruby-red stained glass by mixing gold chloride into molten glass, a process that left tiny gold particles suspended in the glass, says Xia.

The resonance — and the color — can be tuned over a wide range of wavelengths by altering the thickness of the cages’ walls. For biomedical applications, Xia’s lab tunes the cages to 800 nanometers, a wavelength that falls in a window of tissue transparency that lies between 750 and 900 nanometers, in the near-infrared part of the spectrum.

Light in this sweet spot can penetrate as deep as several inches in the body (either from the skin or the interior of the gastrointestinal tract or other organ systems).

The conversion of light to heat arises from the same physical effect as the color. The resonance has two parts. At the resonant frequency, light is typically both scattered off the cages and absorbed by them.

By controlling the cages’ size, Xia’s lab tailors them to achieve maximum absorption.

Passive targeting

“If we put bare nanoparticles into your body,” says Xia, “proteins would deposit on the particles, and they would be captured by the immune system and dragged out of the bloodstream into the liver or spleen.”

To prevent this, the lab coated the nanocages with a layer of PEG, a nontoxic chemical most people have encountered in the form of the laxatives GoLyTELY or MiraLAX. PEG resists the adsorption of proteins, in effect disguising the nanoparticles so that the immune system cannot recognize them.

Instead of being swept from the bloodstream, the disguised particles circulate long enough to accumulate in tumors.

A growing tumor must develop its own blood supply to prevent its core from being starved of oxygen and nutrients. But tumor vessels are as aberrant as tumor cells. They have irregular diameters and abnormal branching patterns, but most importantly, they have thin, leaky walls.

The cells that line a tumor’s blood vessel, normally packed so tightly they form a waterproof barrier, are disorganized and irregularly shaped, and there are gaps between them.

The nanocages infiltrate through those gaps efficiently enough that they turn the surface of the normally pinkish tumor black.

A trial run

In Welch’s lab, mice bearing tumors on both flanks were randomly divided into two groups. The mice in one group were injected with the PEG-coated nanocages and those in the other with buffer solution. Several days later the right tumor of each animal was exposed to a diode laser for 10 minutes.

The team employed several different noninvasive imaging techniques to follow the effects of the therapy. (Welch is head of the oncologic imaging research program at the Siteman Cancer Center of Washington University School of Medicine and Barnes-Jewish Hospital and has worked on imaging agents and techniques for many years.)

During irradiation, thermal images of the mice were made with an infrared camera. As is true of cells in other animals that automatically regulate their body temperature, mouse cells function optimally only if the mouse’s body temperature remains between 36.5 and 37.5 degrees Celsius (98 to 101 degrees Fahrenheit).

At temperatures above 42 degrees Celsius (107 degrees Fahrenheit) the cells begin to die as the proteins whose proper functioning maintains them begin to unfold.

In the nanocage-injected mice, the skin surface temperature increased rapidly from 32 degrees Celsius to 54 degrees C (129 degrees F).

In the buffer-injected mice, however, the surface temperature remained below 37 degrees Celsius (98.6 degrees Fahrenheit).

To see what effect this heating had on the tumors, the mice were injected with a radioactive tracer incorporated in a molecule similar to glucose, the main energy source in the body. Positron emission and computerized tomography (PET and CT) scans were used to record the concentration of the glucose lookalike in body tissues; the higher the glucose uptake, the greater the metabolic activity.

The tumors of nanocage-injected mice were significantly fainter on the PET scans than those of buffer-injected mice, indicating that many tumor cells were no longer functioning.

The tumors in the nanocage-treated mice were later found to have marked histological signs of cellular damage.

Active targeting

The scientists have just received a five-year, $2,129,873 grant from the National Cancer Institute to continue their work with photothermal therapy.

Despite their results, Xia is dissatisfied with passive targeting. Although the tumors took up enough gold nanocages to give them a black cast, only 6 percent of the injected particles accumulated at the tumor site.

Xia would like that number to be closer to 40 percent so that fewer particles would have to be injected. He plans to attach tailor-made ligands to the nanocages that recognize and lock onto receptors on the surface of the tumor cells.

In addition to designing nanocages that actively target the tumor cells, the team is considering loading the hollow particles with a cancer-fighting drug, so that the tumor would be attacked on two fronts.

But the important achievement, from the point of view of cancer patients, is that any nanocage treatment would be narrowly targeted and thus avoid the side effects patients dread.

The TV and radio character the Lone Ranger used only silver bullets, allegedly to remind himself that life was precious and not to be lightly thrown away. If he still rode today, he might consider swapping silver for gold.

###

Cancer and nanotechnology

Filed under: Science, Technology — Tags: , , , , — David Kirkpatrick @ 4:43 pm

I’ve been using HubPages as an outlet for print work that I retain the rights to after selling FNASR to a publication that doesn’t archive its content online. Last week I decided to create a hub offering a clearinghouse of all my blogging on cancer and nanotechnology to date in an effort to get a lot of basic information in one place for people interested in the topic. HubPages doesn’t allow more than three links back to one source and blocked that hub after a couple of days. Sadly they’ve not returned a request to waive the rule in this case because the hub’s purpose was purely informational, not link building for my blog. So here is the hub’s contents to get it back out there, and I’ve been forced to amend the original hub with nothing more than a link back to this post. Sorry for the confusion, but do enjoy the material. And a large raspberry to HubPages for zero communication on a hub that probably deserved an exception to an otherwise sensible rule.

The original hub:

At my personal blog I cover a wide range of topics, but four areas get a lot of attention — business (particularly small business), politics, the energy sector (particularly solar energy) and nanotechnology. One place nanotech is really shining in terms of regular breakthroughs and practical applications is in cancer research and treatment. Following is a recap of two years of nanotech/cancer blogging with dates of, links to the original posts and a summary of the key information. If you are interested in the intersection of nanotechnology and cancer research, this hub is a great place to get started.

April 2, 2008 — Researchers at UCLA developed a “nanoimpeller” nanomachine that stores cancer fighting drugs for release inside cancer cells in response to light.

April 3, 2008 — Researchers at Washington University School of Medicine used drug-coated nanoparticles to deliver fumigillin to cancerous tumors at a 1000-times reduced dose while remaining effective. Fumigillin has neurotoxic side effects at standard dosage.

May 8, 2008 — Researcher at UC San Diego, UC Santa Barbara and MIT developed “nanoworms” that can travel through the bloodstream and target tumors — even tumors too small for conventional detection.

July 17, 2008 — Researchers at Georgia Tech developed a treatment that attaches magnetic nanoparticles to free-floating cancer cells allowing those cells to be removed from the body.

July 28, 2008 — More on the Georgia Tech treatment with image.

September 8, 2008 — Nanoscale gold rods are a key component in heat-based cancer treatment. The gold nanoparticles are designed to bind only with cancer cells.

September 29, 2008 — A hybrid technology from researchers headed by the National Cancer Institute’s Alliance for Nanotechnology in Cancer combining a magnetic nanoparticle, a fluorescent quantum dot and an anticancer drug helps to both image and treat cancerous tumors.

February 2, 2009 — Researchers at the University of Texas M.D. Anderson Cancer Center find hollow gold nanospheres containing a targeting peptide track down melanoma cells and penetrate them allowing for treatment with near-infrared light.

November 29. 2009 — A Nature Materials report finds “nanodiscs” made of a nickel-iron alloy can be subjected to a magnetic field to disrupt the membranes of cancer cells and destroy them. Tests found ten minutes of a low magnetic field killed 90% of cancer cells.

January 14, 2010 — Researchers at the National Cancer Institute’s Centers of Cancer Nanotechnology Excellence found two nanoparticles that work in concert to find, bind with and destroy cancer cells. One particle locates and adheres to the tumor and sensitizes the cancer cells for the second nanoparticle that kills the tumor.

February 11, 2010 — This link goes a press release on gold and nanotech. The release mentions gold nanoparticles efficacy in cancer detection and treatment.

February 17, 2010 — Researchers at the University of Missouri created a sensor based on N/MEMS (micro/nanoelectromechanical systems) known as an acoustic resonant sensor that can test for diseases including breast and prostate cancer. The device could lead to a home cancer detection kit.

March 8, 2010 — Researchers at Cornell found nanoparticles made of a dumbbell-shaped two iron oxide particles sandwiching a gold particle can be loaded with an antibody to specifically target cancer cells then become heated by a near infrared laser killing the cells. This treatment is capable of killing cancer cells while leaving nearby healthy cells unharmed.

Keep in mind this hub only covers nanotech/cancer news that caught my eye over the last couple of years. There are breakthroughs happening every day at labs and universities around the world. The field is still in something of its infancy, but nanotechnology in many forms looks like it might be at least one magic bullet in the fight against cancer.

Update: hit this link for all my blog posts on cancer and nanotech.

March 11, 2010

Cancer and nanotechnology

Filed under: Media, Science, Technology — Tags: , , , , , , — David Kirkpatrick @ 2:19 am

I’ve done a lot of blogging over the last two years on the convergence of cancer research/treatment and nanotechnology. Here’s a HubPages hub that serves as a clearinghouse of those posts to date.

Hit this link if you’d prefer to plow though all the posts here on this blog.

Update 3/13/10 — HubPages doesn’t allow multiple links back to one source, so it pulled my original hub and did not respond to a request to waive the otherwise sensible rule in this case as the hub was not a link-building page for this blog, but simply a method to get a lot of information covering a long time period in one place. Hit this link to find the text of the original hub in its entirety.

March 8, 2010

Cancer killing nanotech assassins

Nanotechnology is proving to have many medical applications, and the bulk of those apps are in cancer research. Here’s the latest from Cornell.

The release:

Like little golden assassins, ‘smart’ nanoparticles identify, target and kill cancer cells

ITHACA, N.Y. – Another weapon in the arsenal against cancer: Nanoparticles that identify, target and kill specific cancer cells while leaving healthy cells alone.

Led by Carl Batt, the Liberty Hyde Bailey Professor of Food Science, the researchers synthesized nanoparticles – shaped something like a dumbbell – made of gold sandwiched between two pieces of iron oxide. They then attached antibodies, which target a molecule found only in colorectal cancer cells, to the particles. Once bound, the nanoparticles are engulfed by the cancer cells.

To kill the cells, the researchers use a near-infrared laser, which is a wavelength that doesn’t harm normal tissue at the levels used, but the radiation is absorbed by the gold in the nanoparticles. This causes the cancer cells to heat up and die.

“This is a so-called ‘smart’ therapy,” Batt said. “To be a smart therapy, it should be targeted, and it should have some ability to be activated only when it’s there and then kills just the cancer cells.”

The goal, said lead author and biomedical graduate student Dickson Kirui, is to improve the technology and make it suitable for testing in a human clinical trial. The researchers are now working on a similar experiment targeting prostate cancer cells.

“If, down the line, you could clinically just target the cancer cells, you could then spare the health surrounding cells from being harmed – that is the critical thing,” Kirui said.

Gold has potential as a material key to fighting cancer in future smart therapies. It is biocompatible, inert and relatively easy to tweak chemically. By changing the size and shape of the gold particle, Kirui and colleagues can tune them to respond to different wavelengths of energy.

Once taken up by the researchers’ gold particles, the cancer cells are destroyed by heat – just a few degrees above normal body temperature – while the surrounding tissue is left unharmed. Such a low-power laser does not have any effect on surrounding cells because that particular wavelength does not heat up cells if they are not loaded up with nanoparticles, the researchers explained.

Using iron oxide – which is basically rust – as the other parts of the particles might one day allow scientists to also track the progress of cancer treatments using magnetic resonance imaging, Kirui said, by taking advantage of the particles’ magnetic properties.

###

The research was funded by the Sloan Foundation and the Ludwig Institute for Cancer Research, which has been a partner with Cornell since 1999 to bring laboratory work to clinical testing. The research is reported in the Feb. 15 online edition of the journal Nanotechnology.

Text by Anne Ju, Cornell Chronicle

January 14, 2010

Using nanotech to attack cancer

Filed under: Science, Technology — Tags: , , , , — David Kirkpatrick @ 3:44 pm

Via KurzweilAI.net — Nanotechnology continues to be a major player in treating cancer.

Nanoparticle Cocktail Targets and Kills Tumors
PhysOrg.com, Jan. 13, 2010

Researchers at the National Cancer Institute’s Centers of Cancer Nanotechnology Excellence have developed a “cocktail” of two different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

One nanomaterial was designed to find and adhere to tumors in mice and then sensitize tumor cells for the second nanoparticle, which kills the tumors.

Read Original Article>>

November 29, 2009

Nanomagnet cancer treatment

Nanoscale magnetic discs actually physically wreck cancer cells. Nanotech is offering a lot of medical treatments, particularly in cancer research.

From the link:

Laboratory tests found the so-called “nanodiscs”, around 60 billionths of a metre thick, could be used to disrupt the membranes of , causing them to self-destruct.

The discs are made from an iron-nickel alloy, which move when subjected to a magnetic field, damaging the cancer cells, the report published in Nature Materials said.

One of the study’s authors, Elena Rozhlova of Argonne National Laboratory in the United States, said subjecting the discs to a low magnetic field for around ten minutes was enough to destroy 90 percent of cancer cells in tests.

February 2, 2009

Nanotech fighting cancer

From KurzweilAI.net— It seems like nanotech might be the magic bullet for cancer. This technique uses gold nanospheres to fight melanoma.

Targeted nanospheres find, penetrate, then fuel burning of melanoma
PhysOrg.com, Feb. 2, 2009

Hollow gold nanospheres equipped with a targeting peptide find melanoma cells, penetrate them deeply, and then cook the tumor when bathed with near-infrared light, University of Texas M. D. Anderson Cancer Center researchers have shown.

 
Read Original Article>>

September 29, 2008

Nanotech is really looking like the cancer “golden gun”

From KurzweilAI.net — Hybrid nanotechnology is leading the fight against cancer. This breakthrough comes from the National Cancer Institute’s Alliance for Nanotechnology in Cancer.

Hybrid Nanoparticles Image and Treat Tumors
PhysOrg.com, Sep. 26, 2008

Combining a magnetic nanoparticle, a fluorescent quantum dot, and an anticancer drug within a lipid-based nanoparticle, a multi-institutional research team headed by the National CancerInstitute’s (NCI) Alliance for Nanotechnology in Cancer has created a single agent that can image and treat tumors, while avoiding detection by the immune system, enabling the particle to remain in the body for extended periods of time.

 
Read Original Article>>

September 8, 2008

Gold nanorods help fight cancer

Filed under: Science, Technology — Tags: , , , , , — David Kirkpatrick @ 11:00 pm

Nanoscale gold rods are a key component in heat-based cancer treatment.

From the link:

Cancer cells are relatively temperature-sensitive. This is exploited in treatments involving overheating of parts of the cancer patient’s body. One highly promising method is photoinduced hyperthermia, in which light energy is converted to heat. Gold nanoparticles absorb light very strongly in the near infrared, a spectral region that is barely absorbed by tissue. The absorbed light energy causes the gold particles to vibrate and is dissipated into the surrounding area as heat. The tiny gold particles can be functionalized so that the specifically bind to tumor cells. Thus, only cells that contain gold particles are killed off.

The problem? Ordinary spherical gold particles do not efficiently convert the light energy into heat; only rod-shaped particles will do. Unfortunately, the additives needed to crystallize the rod-shaped particles from aqueous solutions are cytotoxic.

The team headed by Michael R. Bockstaller is now pursuing a new strategy: instead of aqueous solution, they chose to use an ionic liquid as their medium of crystallization. Ionic liquids are “liquid salts”, organic compounds that exist as oppositely charged ions, but in the liquid state. In this way, the researchers have been able to produce gold nanorods without the use of any cytotoxic additives.

M. Bockstaller and his team have synthesized gold nanorods using an ionic liquid as a solvent. Gold nanorods are interesting starting materials in cancer therapy. (c)Wiley-VCH 2008

M. Bockstaller and his team have synthesized gold nanorods using an ionic liquid as a solvent. Gold nanorods are interesting starting materials in cancer therapy. (c)Wiley-VCH 2008

 

July 28, 2008

Nanomagnets fighting cancer

From KurzweilAI.net — Nanoparticle-sized magnets specially coated to “catch” ovarian cancer cells are a new cancer-fighting treatment.

 

Magnets Capture Cancer Cells
Technology Review, July 22, 2008

Georgia Institute of Technology researchers have developed magnetic nanoparticles (coated with a specialized targeting peptide molecule) designed to latch onto ovarian cancer cells in mice and drag them out of the abdominal fluid to prevent metastasis.


Nanoparticles (red) on cancer cell

See Also New Nano Weapon against Cancer

 
Read Original Article>>

July 17, 2008

Nanotech fighting cancer

Filed under: Science, Technology — Tags: , , , , — David Kirkpatrick @ 1:58 am

This is a pretty exciting breakthrough in fighting cancer through nanotechnology.

Hit the link for a video, and here’s the lede:

Scientists at Georgia Tech have developed a potential new treatment against cancer that attaches magnetic nanoparticles to cancer cells, allowing them to be captured and carried out of the body. The treatment, which has been tested in the laboratory and will now be looked at in survival studies, is detailed online in the Journal of the American Chemical Society.

“We’ve been able to use magnetic nanoparticles to capture free-floating cancer cells and then take them out of the body,” said John McDonald, chair of the School of Biology at Georgia Tech and chief research scientist at the Ovarian Cancer Institute. “This technology may be of special importance in the treatment of ovarian cancer where the malignancy is typically spread by free-floating cancer cells released from the primary tumor into the abdominal cavity.”

April 3, 2008

Nanoparticles fight cancer with targeted doses

Another nanotech advance in cancer treatment.

From KurzweilAI.net:

Nanoparticle delivery sytem for anti-tumor toxins reduces drug dose 1,000 times
KurzweilAI.net, April 3, 2008Washington University School of Medicine researchers using drug-coated nanoparticles to deliver fumagillin (a fungal toxin cancer treatment) to tumors found that a drug dose 1,000 times lower than used previously still significantly slowed tumor growth.

Fumagillin can have neurotoxic side effects at the high doses required with standard methods. The fumagillin nanoparticles were effective in very low doses because they were designed to concentrate where tumors create new blood vessels.

Washington University School of Medicine News Release

August 26, 2010

Cool nanotech image — microneedles

Cool to look, even more cool when put into practice. Microneedles can deliver quantum dots into skin and should lead to new diagnosis and treatment of medical conditions such as skin cancer.

And now, the image:

Hollow microneedles open the door to new techniques for diagnosing and treating a variety of medical conditions, including skin cancer. Image reproduced by permission of the Royal Society of Chemistry.

For more on microneedles, here’s the full release.

July 8, 2010

Drug delivery system, electromagnetic fields and nanotech

Medical news about nanotechnology.

The release:

Researchers develop drug delivery system using nanoparticles triggered by electromagnetic field

KINGSTON, R.I. July 8, 2010 – A new system for the controlled delivery of pharmaceutical drugs has been developed by a team of University of Rhode Island chemical engineers using nanoparticles embedded in a liposome that can be triggered by non-invasive electromagnetic fields.

The discovery by URI professors Geoffrey Bothun and Arijit Bose and graduate student Yanjing Chen was published in the June issue of ACS Nano.

According to Bothun, liposomes are tiny nanoscale spherical structures made of lipids that can trap different drug molecules inside them for use in delivering those drugs to targeted locations in the body. The superparamagnetic iron oxide nanoparticles the researchers embed in the shell of the liposome release the drug by making the shell leaky when heat-activated in an alternating current electromagnetic field operating at radio frequencies.

“We’ve shown that we can control the rate and extent of the release of a model drug molecule by varying the nanoparticle loading and the magnetic field strength,” explained Bothun. “We get a quick release of the drug with magnetic field heating in a matter of 30 to 40 minutes, and without heating there is minimal spontaneous leakage of the drug from the liposome.”

Bothun said that the liposomes self-assemble because portions of the lipids are hydrophilic – they have a strong affinity for water – and others are hydrophobic – they avoid water. When he mixes lipids and nanoparticles in a solvent, adds water and evaporates off the solvent, the materials automatically assemble themselves into liposomes. The hydrophobic nanoparticles and lipids join together to form the shell of the liposome, while the water-loving drug molecules are captured inside the spherical shell.

“The concept of loading nanoparticles within the hydrophobic shell to focus the activation is brand new,” Bothun said. “It works because the leakiness of the shell is ultimately what controls the release of the drugs.”

The next step in the research is to design and optimize liposome/nanoparticle assemblies that can target cancer cells or other disease-causing cells. In vitro cancer cell studies are already underway in collaboration with URI pharmacy professor Matthew Stoner.

“We are functionalizing the liposomes by putting in different lipids to help stabilize and target them so they can seek out particular cancer cell types,” he said. “We are building liposomes that will attach to particular cells or tumor regions.”

Bothun said that research on nanomedicine shows great promise, but there are still many challenges to overcome, and the targeting of appropriate cells may be the greatest challenge.

“Any ability to target the drug is better than a drug that goes everywhere in your system and generates off-target effects,” he said, noting that the hair loss and nausea from anti-cancer drugs are the result of the high drug concentrations needed for treatment and the drug’s affect on non-target cells. “If you can get an assembly to a targeted site without losing its contents in the process, that’s the holy grail.”

###

May 27, 2010

Nanotech and optics

Very cool findings about light-activated nanoshells.

The release:

Optical Legos: Building nanoshell structures

Self-assembly method yields materials with unique optical properties

IMAGE: Heptamers containing seven nanoshells have unique optical properties.

Click here for more information.

HOUSTON — (May 27, 2010) — Scientists from four U.S. universities have created a way to use Rice University’s light-activated nanoshells as building blocks for 2-D and 3-D structures that could find use in chemical sensors, nanolasers and bizarre light-absorbing metamaterials. Much as a child might use Lego blocks to build 3-D models of complex buildings or vehicles, the scientists are using the new chemical self-assembly method to build complex structures that can trap, store and bend light.

The research appears in this week’s issue of the journal Science.

“We used the method to make a seven-nanoshell structure that creates a particular type of interference pattern called a Fano resonance,” said study co-author Peter Nordlander, professor of physics and astronomy at Rice. “These resonances arise from peculiar light wave interference effects, and they occur only in man-made materials. Because these heptamers are self-assembled, they are relatively easy to make, so this could have significant commercial implications.”

Because of the unique nature of Fano resonances, the new materials can trap light, store energy and bend light in bizarre ways that no natural material can. Nordlander said the new materials are ideally suited for making ultrasensitive biological and chemical sensors. He said they may also be useful in nanolasers and potentially in integrated photonic circuits that run off of light rather than electricity.

The research team was led by Harvard University applied physicist Federico Capasso and also included nanoshell inventor Naomi Halas, Rice’s Stanley C. Moore Professor in Electrical and Computer Engineering and professor of physics, chemistry and biomedical engineering.

Nordlander, the world’s leading theorist on nanoparticle plasmonics, had predicted in 2008 that a heptamer of nanoshells would produce Fano resonances. That paper spurred Capasso’s efforts to fabricate the structure, Nordlander said.

The new self-assembly method developed by Capasso’s team was also used to make magnetic three-nanoshell “trimers.” The optical properties of these are described in the Science paper, which also discusses how the self-assembly method could be used to build even more complex 3-D structures.

Nanoshells, the building blocks that were used in the new study, are about 20 times smaller than red blood cells. In form, they resemble malted milk balls, but they are coated with gold instead of chocolate, and their center is a sphere of glass. By varying the size of the glass center and the thickness of the gold shell, Halas can create nanoshells that interact with specific wavelengths of light.

“Nanoshells were already among the most versatile of all plasmonic nanoparticles, and this new self-assembly method for complex 2-D and 3-D structures simply adds to that,” said Halas, who has helped develop a number of biological applications for nanoshells, including diagnostic applications and a minimally invasive procedure for treating cancer.

###

Additional co-authors of the new study include Rice graduate students Kui Bao and Rizia Bardhan; Jonathan Fan and Vinothan Manoharan, both of Harvard; Chihhui Wu and Gennady Shvets, both of the University of Texas at Austin; and Jiming Bao of the University of Houston. The research was supported by the National Science Foundation, the Air Force Office of Scientific Research, the Department of Defense, the Robert A. Welch Foundation, the Department of Energy and Harvard University.

PhysOrg covers this story here.

More nanotech medical treatment

Filed under: Science, Technology — Tags: , , , , , — David Kirkpatrick @ 4:23 pm

Both via KurzweilAI.net, and both as a follow-up to my previous post on killing tumors with gold nanoparticles.

First up is using carbon nanotubes as a radiotherapy delivery system:

Nanocapsule delivers radiotherapy
PhysOrg.com, May 26, 2010

Oxford University chemists have encapsulated radionuclides within carbon nanotubes and set new records for highly concentrated in vivo radiodosage, while demonstrating zero leakage of isotopes to high-affinity organs, such as the thyroid.


Artist’s rendition of nanocapsules (Gerard Tobias)
Read Original Article>>

And second is using nanoporous particles as a molecular therapy deliver system to tumors:

Nanoporous Particles Deliver Novel Molecular Therapies to Tumors
PhysOrg.com, May 26, 2010

Using nanoporous silicon particles, two teams of investigators have created drug delivery vehicles capable of ferrying labile molecular therapies deep into the body, creating new opportunities for developing innovative anticancer therapies.
Read Original Article>>

Killing tumors with gold nanoparticles

Via KurzweilAI.net — The latest in fighting cancer with nanotechnology.

Self-Assembling Gold Nanoparticles Use Light to Kill Tumor Cells
PhysOrg.com, May 26, 2010

Researchers at the University of California, Los Angeles, have developed a method for creating supramolecular assemblies of gold nanoparticles that function as highly efficient photothermal agents for delivery to tumors, using a laser beam to heat the nanoparticles above 374 degreesC, the temperature at which explosive microbubbles form.
Read Original Article>>

May 13, 2010

Molecular nanobots

Via KurzweilAI.net — very cool! As always, I’ve included the entire KurzweilAI post. This one is a bit longer than usual.

How to make a molecular nanobot
KurzweilAI.net, May 13, 2010

Scientists have programmed an autonomous molecular nanorobot made out of DNA to start, move, turn, and stop while following a DNA track.


(Paul Michelotti)

The development could ultimately lead to molecular systems that could be used for medical therapeutic devices and molecular-scale reconfigurable robots—robots made of many simple units that can reposition or even rebuild themselves to accomplish different tasks.

Molecular robots, in theory, could be programmed to sense their environment (say, the presence of disease markers on a cell), make a decision (that the cell is cancerous and needs to be neutralized), and act on that decision (deliver a cargo of cancer-killing drugs). Or they could be programmed to assemble complex molecular products.

“In normal robotics, the robot itself contains the knowledge about the commands, but with individual molecules, you can’t store that amount of information, so the idea instead is to store information on the commands on the outside,” says Nils G. Walter, professor of chemistry and director of the Single Molecule Analysis in Real-Time (SMART) Center at the University of Michigan in Ann Arbor. And you do that by “imbuing the molecule‘s environment with informational cues,” says Milan N. Stojanovic, a faculty member in the Division of Experimental Therapeutics at Columbia University.

“We were able to create such a programmed or ‘prescribed’ environment using DNA origami,” explains Hao Yan, professor of chemistry and biochemistry at Arizona State University. DNA origami is a type of self-assembledstructure made from DNA that can be programmed to form nearly limitless shapes and patterns. Exploiting the sequence-recognition properties of DNA base pairing, DNA origami are created from a long single strand of DNA and a mixture of different short synthetic DNA strands that bind to and “staple” the long DNA into the desired shape. The origami used in the Nature study was a rectangle that was 2 nanometers (nm) thick and roughly 100 nm on each side.

The researchers constructed a trail of molecular “bread crumbs” on the DNA origami track by stringing additional single-stranded DNA molecules, or oligonucleotides, off the ends of the staples. These represent the cues that tell the molecular robots what to do—start, walk, turn left, turn right, or stop, for example—akin to the commands given to traditional robots.

To build the 4-nm-diameter molecular robot, the researchers started with a common protein called streptavidin, which has four symmetrically placed binding pockets for a chemical moiety called biotin. Each robot leg is a short biotin-labeled strand of DNA, “so this way we can bind up to four legs to the body of our robot,” Walter says. “It’s a four-legged spider,” quips Stojanovic. Three of the legs are made of enzymatic DNA, which is DNA that binds to and cuts a particular sequence of DNA. The spider also is outfitted with a “start strand”—the fourth leg—that tethers the spider to the start site (one particular oligonucleotide on the DNA origami track). “After the robotis released from its start site by a trigger strand, it follows the track by binding to and then cutting the DNA strands extending off of the staple strands on the molecular track,” Stojanovic explains.

“Once it cleaves,” adds Yan, “the product will dissociate, and the leg will start searching for the next substrate.” In this way, the spider is guided down the path laid out by the researchers. Finally, explains Yan, “the robot stops when it encounters a patch of DNA that it can bind to but that it cannot cut,” which acts as a sort of flypaper.

Using atomic force microscopy and single-molecule fluorescence microscopy, the researchers were able to watch spiders crawling over the origami, showing that they were able to guide their molecular robots to follow four different paths.

More info: Caltech news and Molecular robots guided by prescriptive landscapes

May 5, 2010

Providing disadvantages along with advantages helps nanotech acceptance

One of my more popular all time posts is “Nanotechnology does have drawbacks” from September 2008 so that tells me people regularly search for the negative side of nanotech. The topic is something that heads toward higher level science and the term gets tossed around a lot — and a lot of the time incorrectly as far as that goes — so people are naturally curious about exactly what is nanotechnology and how is it good and bad.

This survey, not surprisingly, found that providing information about the risks of nanotech increases public support among those who have heard of the field. Of course it also found support decreased among those who’d never heard the term once they were frightened by the potential drawbacks. I’m guessing scientific fact that sounds like scientific fiction can be pretty scary to someone who’s not familiar with what it can, and might, do both positive and negative.

From the second link, the release:

Survey: Hiding Risks Can Hurt Public Support For Nanotechnology

Release Date: 05.04.2010

A new national survey on public attitudes toward medical applications and physical enhancements that rely on nanotechnology shows that support for the technology increases when the public is informed of the technology’s risks as well as its benefits – at least among those people who have heard of nanotechnology. The survey, which was conducted by researchers at North Carolina State University and Arizona State University (ASU), also found that discussing risks decreased support among those people who had never previously heard of nanotechnology – but not by much.

“The survey suggests that researchers, industries and policymakers should not be afraid to display the risks as well as the benefits of nanotechnology,” says Dr. Michael Cobb, an associate professor of political science at NC State who conducted the survey. “We found that when people know something about nanotechnologies for human enhancement, they are more supportive of it when they are presented with balanced information about its risks and benefits.”

The survey was conducted by Cobb in collaboration with Drs. Clark Miller and Sean Hays of ASU, and was funded by the Center for Nanotechnology in Society at ASU.

However, talking about risks did not boost support among all segments of the population. Those who had never heard of nanotechnology prior to the survey were slightly less supportive when told of its potential risks.

In addition to asking participants how much they supported the use of nanotechnology for human enhancements, they were also asked how beneficial and risky they thought these technologies would be, whether they were worried about not getting access to them, and who should pay for them – health insurance companies or individuals paying out-of-pocket. The potential enhancements addressed in the survey run the gamut from advanced cancer treatments to bionic limbs designed to impart greater physical strength.

One segment of participants was shown an image of an unrealistic illustration meant to represent a nanoscale medical device. A second segment was shown the image and given a “therapeutic” framing statement that described the technology as being able to restore an ill person to full health. A third segment was given the image, along with an “enhancement” framing statement that described the technology as being able to make humans faster, stronger and smarter. Two additional segments were given the image, the framing statements and information about potential health risks. And a final segment of participants was not given the image, a framing statement or risk information.

The survey found that describing the technology as therapeutic resulted in much greater public support for the technology, as well as a greater perception of its potential benefits. The therapeutic frame also resulted in increased support for health insurance coverage of nanotech treatments once they become available, and increased concerns that people wouldn’t be able to afford such treatments without insurance coverage.

“These findings suggest that researchers, policymakers and industries would be well advised to focus their research efforts on developing therapeutic technologies, rather than enhancements, because that is the area with the greatest public support,” Cobb says.

The use of the nanotech image did not have a significant overall impact on participants’ support, but did alarm people who were not previously familiar with nanotechnology – making them less likely to support it.

The survey was conducted by Knowledge Networks between April 2-13. The survey included 849 participants, and has a margin of error of plus or minus 3.3 percent.

NC State’s Department of Political Science is part of the university’s College of Humanities and Social Sciences.

This illustration was used to represent a nanoscale medical device in the national survey on public attitudes towards the use of nanotechnology for human enhancement.This illustration was used to represent a nanoscale medical device in the national survey on public attitudes towards the use of nanotechnology for human enhancement.

April 6, 2010

Nanotech and medicine

New research on how carbon nanotubes may be used in medical applications.

The release:

[PRESS RELEASE, 5 April 2010] A team of Swedish and American scientists has shown for the first time that carbon nanotubes can be broken down by an enzyme – myeloperoxidase (MPO) – found in white blood cells. Their discoveries are presented in Nature Nanotechnology and contradict what was previously believed, that carbon nanotubes are not broken down in the body or in nature. The scientists hope that this new understanding of how MPO converts carbon nanotubes into water and carbon dioxide can be of significance to medicine.

“Previous studies have shown that carbon nanotubes could be used for introducing drugs or other substances into human cells,” says Bengt Fadeel, associate professor at the Swedish medical university Karolinska Institutet. “The problem has been not knowing how to control the breakdown of the nanotubes, which can caused unwanted toxicity and tissue damage. Our study now shows how they can be broken down biologically into harmless components.”

Carbon nanotubes are a material consisting of a single layer of carbon atoms rolled into a tube with a diameter of only a couple of nanometres (1 nanometer = 1 billionth of a metre) and a length that can range from tens of nanometres up to several micrometers. Carbon nanotubes are lighter and stronger than steel, and have exceptional heat-conductive and electrical properties. They are manufactured on an industrial scale, mainly for engineering purposes but also for some consumer products.

Carbon nanotubes were once considered biopersistent in that they did not break down in body tissue or in nature. In recent years, research has shown that laboratory animals exposed to carbon nanotubes via inhalation or through injection into the abdominal cavity develop severe inflammation. This and the tissue changes (fibrosis) that exposure causes lead to impaired lung function and perhaps even to cancer. For example, a year or two ago, alarming reports by other scientists suggested that carbon nanotubes are very similar to asbestos fibres, which are themselves biopersistent and which can cause lung cancer (mesothelioma) in humans a considerable time after exposure.

This current study thus represents a breakthrough in nanotechnology and nanotoxicology, since it clearly shows that endogenous MPO can break down carbon nanotubes. This enzyme is expressed in certain types of white blood cell (neutrophils), which use it to neutralise harmful bacteria. Now, however, the researchers have found that the enzyme also works on carbon nanotubes, breaking them down into water and carbon dioxide. The researchers also showed that carbon nanotubes that have been broken down by MPO no longer give rise to inflammation in mice.

“This means that there might be a way to render carbon nanotubes harmless, for example in the event of an accident at a production plant,” says Dr Fadeel. “But the findings are also relevant to the future use of carbon nanotubes for medical purposes.”

The study was led by researchers at Karolinska Institutet, the University of Pittsburgh and the National Institute for Occupational Safety and Health (NIOSH), and was financed in part through grants from the National Institutes of Health (NIH) and the Seventh Framework Programme of the European Commission. The work was conducted as part of the NANOMMUNE project, which is coordinated by associate professor Bengt Fadeel of the Institute of Environmental Medicine, Karolinska Institutet, and which comprises a total of thirteen research groups in Europe and the USA.

March 17, 2010

DNA nanotubes as a drug delivery system

Medical nanotech news from McGill University.

The release:

DNA nanotechnology breakthrough offers promising applications in medicine

McGill researchers create DNA nanotubes able to carry and selectively release materials

This release is available in French.

A team of McGill Chemistry Department researchers led by Dr. Hanadi Sleiman has achieved a major breakthrough in the development of nanotubes – tiny “magic bullets” that could one day deliver drugs to specific diseased cells. Sleiman explains that the research involves taking DNA out of its biological context. So rather than being used as the genetic code for life, it becomes a kind of building block for tiny nanometre-scale objects.

Using this method, the team created the first examples of DNA nanotubes that encapsulate and load cargo, and then release it rapidly and completely when a specific external DNA strand is added. One of these DNA structures is only a few nanometres wide but can be extremely long, about 20,000 nanometres. (A nanometre is one-10,000th the diameter of a human hair.)

Until now, DNA nanotubes could only be constructed by rolling a two-dimensional sheet of DNA into a cylinder. Sleiman’s method allows nanotubes of any shape to be formed and they can either be closed to hold materials or porous to release them. Materials such as drugs could then be released when a particular molecule is present.

One of the possible future applications for this discovery is cancer treatment. However, Sleiman cautions, “we are still far from being able to treat diseases using this technology; this is only a step in that direction. Researchers need to learn how to take these DNA nanostructures, such as the nanotubes here, and bring them back to biology to solve problems in nanomedicine, from drug delivery, to tissue engineering to sensors,” she said.

The team’s discovery was published on March 14, 2010 in Nature Chemistry. The research was made possible with funding from the National Science and Engineering Research Council and the Canadian Institute for Advanced Research.

###

On the Web: http://www.hanadisleiman.com

Video link: http://snurl.com/uw2q1

March 4, 2010

Nanotech and skin care

Nanotechnology is changing diverse areas from electronics to medicine and even skin care. Here’s a release from the American Academy of Dermatology that just hit the inbox:

Sizing Up Nanotechnology: How Nanosized Particles May Affect Skin Care Products

MIAMI, March 4 /PRNewswire-USNewswire/ — The rapidly growing field of nanotechnology and its future use in cosmetic products holds both enormous potential and potential concern for consumers. Currently, major cosmetic manufacturers have imposed a voluntary ban on the use of nanoparticles in products while they await a ruling from the Food and Drug Administration (FDA) regarding the safety of this technology.  However, these manufacturers know that when ingredients in products such as sunscreens and anti-aging products are converted into nanosized particles, the end product displays unique properties that can benefit the skin in ways that otherwise could not be achieved using larger-sized particles.

Speaking today at the 68th Annual Meeting of the American Academy of Dermatology (Academy), dermatologist Adnan Nasir, MD, PhD, FAAD, clinical assistant professor in the department of dermatology at the University of North Carolina in Chapel Hill, presented an overview of nanotechnology and how nanoparticles may eventually be used in cosmetic products.

“Research in the area of nanotechnology has increased significantly over the years, and I think there will be considerable growth in this area in the near future,” said Dr. Nasir. “The challenge is that a standard has not been set yet to evaluate the safety and efficacy of topical products that contain nanosized particles.”

Nanotechnology: On the Plus Side

Products incorporating nanotechnology are being developed and manufactured at an ever-growing rate, especially among clothing manufacturers that incorporate nanomaterials into fabrics to enhance stain and wrinkle resistance, and water repellence.  However, Dr. Nasir explained that a substantial proportion of patents issued for nanotechnology-based discoveries are currently in the realm of cosmetic and consumer skin care products. In fact, the cosmetic industry leads all other industries in the number of patents for nanoparticles, which have the potential to enhance sunscreens, shampoos and conditioners, lipsticks, eye shadows, moisturizers, deodorants, after-shave products and perfumes.

One example of how nanoparticles are being considered for use is to improve some of the undesirable properties of skin care products. Dr. Nasir explained that when certain ingredients are included in micrometer-sized particles, which are considerably larger than nanosized particles, the result is a product than can be cosmetically unappealing.

For example, one common ingredient in broad-spectrum sunscreens, which protect the skin from both UVA and UVB rays, is avobenzone, which can make a sunscreen greasy and very noticeable when applied to the skin. Since titanium, another common sunscreen ingredient, requires an oily mixture to dissolve, a white residue can be apparent on the skin upon application. However, when these active ingredients in sunscreens are converted into nanoparticles, they can be suspended in less greasy formulations – which seem to vanish on the skin and do not leave a residue – while retaining their ability to block UVA and UVB light.

“While widespread use of this technology is currently under evaluation, I think one of the main benefits of nanoparticles used in sunscreens will be that the particles can fit into all the nooks and crannies of the skin, packing more protection and more even coverage on the skin’s surface than microsized particles,” said Dr. Nasir. “Since sunscreen formulations using nanoparticles may be more cosmetically appealing and seem to vanish when applied, consumers may be more inclined to use them on a regular basis.”

Nanotechnology also is generating excitement for its potential use in anti-aging products. When properly engineered, nanomaterials may be able to topically deliver retinoids, antioxidants and drugs such as botulinum toxin or growth factors for rejuvenation of the skin in the future.

In anti-aging products, Dr. Nasir added that nanotechnology may allow active ingredients that would not normally penetrate the skin to be delivered to it. For example, vitamin C is an antioxidant that helps fight age-related skin damage which works best below the top layer of skin. In bulk form, vitamin C is not very stable and has difficulty penetrating the skin. However, in future formulations, nanotechnology may increase the stability of vitamin C and enhance its ability to penetrate the skin.

“Since anti-aging products that contain nanoparticles of antioxidants will be harder to make, we expect that these products will cost more than products using traditional formulations,” said Dr. Nasir. “Once these products are determined to be safe, the consumer will have to decide if the increased costs are worth the added benefits.”

Nanotechnology: Future Melanoma Treatment

Researchers also are reviewing the use of nanomaterials for the treatment of melanoma. In particular, gold, when turned into a nanomaterial called nanoshells, has been shown to be a useful treatment for melanoma in animal studies.

According to Dr. Nasir, gold nanoshells can be engineered to absorb specific wavelengths of light.  If the wavelength of light unique to a particular type of gold nanoshell is used on it, the particle generates heat. In one animal study done at MD Anderson Cancer Center in Houston, investigators joined gold nanoshells with a molecule which homes to melanoma.  When these gold nanoshells are injected into mice harboring melanoma, the nanoshells accumulate in the cancerous tissue.  When mice are illuminated with the proper wavelength of light, their tumors, laden with gold nanoshells, heat up and are effectively killed. The surrounding tissue, which lacks targeted gold nanoshells, is unharmed.

“Nanotechnology holds promise for new non-invasive treatment methods, particularly for challenging dermatologic conditions, such as atopic dermatitis and ichthyosis,” said Dr. Nasir.

Nanotechnology: More Consumer Information Needed

Because the skin is the first point of contact and the first line of defense for newly manufactured nanomaterials, Dr. Nasir noted that many dermatologists have concerns about the potential health risks posed by nanotechnology. “Although nanotechnology is an exciting area that holds enormous potential,” said Dr. Nasir, “we anxiously await the FDA’s review of the safety of nanoparticles which will determine their future role in skin care products.”

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org.

Source: American Academy of Dermatology

Web Site:  http://www.aad.org/

February 17, 2010

Home cancer detection …

… may not be all that far off. The release doesn’t get into any sort of time-to-market predictions, but if this becomes reality it will be one amazing medical breakthrough.

The release:

Small Liquid Sensor May Detect Cancer Instantly, Could Lead to Home Detection Kit

MU researcher developing a sensor to detect diseases, such as breast cancer, in bodily fluids

Feb. 17, 2010

COLUMBIA, Mo. – What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.

“Many disease-related substances in liquids are not easily tracked,” said Jae Kwon, assistant professor of electrical and computer engineering at MU. “In a liquid environment, most sensors experience a significant loss of signal quality, but by using highly sensitive, low-signal-loss acoustic resonant sensors in a liquid, these substances can be effectively and quickly detected — a brand-new concept that will result in a noninvasive approach for breast cancer detection.”

Kwon’s real-time, special acoustic resonant sensor uses micro/nanoelectromechanical systems (M/NEMS), which are tiny devices smaller than the diameter of a human hair, to directly detect diseases in body fluids. The sensor doesn’t require bulky data reading or analyzing equipment and can be integrated with equally small circuits, creating the potential for small stand-alone disease-screening systems. Kwon’s sensor also produces rapid, almost immediate results that could reduce patient anxiety often felt after waiting for other detection methods, such as biopsies, which can take several days or weeks before results are known.

“Our ultimate goal is to produce a device that will simply and quickly diagnose multiple specific diseases, and eventually be used to create ‘point of care’ systems, which are services provided to patients at their bedsides,” Kwon said. “The sensor has strong commercial potential to be manifested as simple home kits for easy, rapid and accurate diagnosis of various diseases, such as breast cancer and prostate cancer.”

Last January, Kwon was awarded a $400,000, five-year National Science Foundation CAREER Award to continue his effort on this sensor research. The CAREER award is the NSF’s most prestigious award in support of junior faculty members who exemplify the role of teacher-scholars through outstanding research, excellent teaching, and the integration of education and research. Kwon’s sensor research has been published in the IEEE International Conference on Solid-state, Sensors, Actuators and Microsystems and the IEEE Conference on Sensors.

–30–

February 11, 2010

Gold and nanotechnology

Filed under: Business, Science, Technology — Tags: , , , , — David Kirkpatrick @ 4:02 am

A release from the World Gold Council and Cientifica Ltd., smoking hot from the inbox this morning (the crazy formatting is from the original and I didn’t feel like fixing it, so apologies for reading difficulties):

Gold at Forefront of ‘Nanotechnology Revolution’

LONDON, February 11/PRNewswire/ —

– World Gold Council Research Paper Demonstrates Important Applications
in Development Using Gold Nanoparticles

World Gold Council (WGC) has today published ‘Gold for Good: Gold and
nanotechnology in the age of innovation’, a research paper detailing new
scientific and technological innovations using gold. The report, which was
produced in conjunction with Cientifica Ltd, the world’s leading source of
global business and investor intelligence about nanotechnologies,
demonstrates how gold nanoparticles offer the potential to overcome many of
the serious issues facing mankind over the coming decades.

Gold nanoparticles exhibit a variety of unique properties which, when
harnessed and manipulated effectively, lead to materials whose uses are both
far-ranging in their potential and cost effective. This report explores the
many different applications that are being developed across the fields of
health, environment and technology.

Trevor Keel, Nanotechnology Project Manager at World Gold Council said:

“The opportunities and possibilities identified in this report are just a
subset of the amazing scope to use gold in the era of nanotechnology. As a
readily available and well understood material, gold nanoparticles are ideal
for use in a vast array of applications that improve our lives. WGC is
looking to promote and invest in the development of gold-based innovations
through Innovations Partnerships, so that the full benefits of gold
nanotechnology can be realized.”

Tim Harper, founder of Cientifica Ltd, said:

“Over the last decade, almost $50 billion of government funding has been
invested into nanotechnologies, and this investment is now starting to bear
fruit with a steady stream of commercially viable nanotechnologies which are
positively impacting human health, the environment and technology. This paper
demonstrates the many varied applications in which gold nanotechnology can
improve society’s standard of living.”

Health: Gold has a long history in the biomedical field stretching back
almost five thousand years. However the dawn of the ‘nano-age’ has really
broadened the potential of gold in biomedical applications and today, gold
nanoparticles are being employed in entirely novel ways to achieve
therapeutic effects.

Tumor targeting technologies which exploit gold’s inherent
bio-compatibility are being developed to deliver drugs directly into
cancerous tumours. Additionally, simple, cost effective and sensitive
diagnostic tests are being developed for the early detection of prostate and
other cancers.

Environment: Environmental concerns have never been more prominent –
energy and clean water scarcity, global warming and pollution are all major
issues that need to be addressed. Gold nano-particle based technologies are
showing great promise in providing solutions to a number of environmentally
important issues from greener production methods of the chemical feedstocks,
to pollution control and water purification.

Gold-based catalysts are being developed that can effectively prevent the
release of highly toxic forms of mercury into the atmosphere, the reduction
of chemicals from green feedstock, and also for water purification and
contaminant detection. In addition, gold is being used in meeting the
challenge of constructing cost effective and efficient fuel cells, a key
‘clean-energy’ technology of the future.

Advanced technology: Gold is already a well established
material in the electronics industry and the use of gold can only increase as
the worlds of electronics and nanotechnology interact further in the future.
Gold is being developed for conductive nanoparticle inks for plastic
electronics because of its material compatibility, inherent durability and
proven track record of reliability. Gold nanotechnologies have also been
shown to offer functional benefits for visual display technologies like touch
sensitive screens and potentially for use in advanced data storage
technologies including advanced flash memory devices.

The full paper can be downloaded from:

http://www.gold.org/assets/file/rs_archive/gold_and_nanotechnology_in_the
_age_of_innovation.pdf

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser’s URL address field. Remove the
space if one exists.)

OR

http://cientifica.eu/blog/white-papers/gold/

Innovation Partnerships

World Gold Council works directly with partner companies via Innovation
Partnerships. These support research and development of new practical
applications for the metal, drawing on a genuine commercial market
requirement for innovation. Partner organisations include (but are not
limited to) precious metal, chemical, electronics, materials and biomedical
companies, ranging from small enterprises through to established
international businesses. Interested companies are invited to contact World
Gold Council for further details.

During 2009-2010 World Gold Council is particularly interested in
receiving proposals relating to the following areas:

Industrial catalysts (including catalysts for pollution control and
chemical processing)

Biomedical applications (including medical diagnostics, therapeutics and
materials)

Advanced electronics (including any technology or component likely to be
used in next-generation devices)

Fuel cell systems (including applications both within the fuel cell
structure and hydrogen processing infrastructure)

Optical materials (including nanotechnology, chemicals and coatings)

Companies interested in collaborating with World Gold Council
are invited to make contact.

Notes to Editors:

World Gold Council

World Gold Council’s mission is to stimulate and sustain the demand for
gold and to create enduring value for its stakeholders. It is funded by the
world’s leading gold mining companies. For further information please visit
http://www.gold.org.

Cientifica

Cientifica Ltd, based in London, is one of the world’s best-respected
consultancy companies in the field of emerging technologies and technology
commercialization. It provides global business intelligence and strategic
consulting services to industry, governments and investors worldwide.

http://www.cientifica.eu

January 19, 2010

Nanotech to replace drug-releasing stents

Via KurzweilAI.net — Nanotechnology is getting a reputation for innovative cancer treatments, but this breakthrough shows nanotech has a lot to offer many areas of medicine.

New ‘nanoburrs’ could add to arsenal of therapies against heart disease
Physorg.com, Jan. 18, 2010

Researchers at MIT and Harvard Medical School have built targeted nanoparticles that can cling to artery walls and slowly release medicine, an advance that potentially provides an alternative to drug-releasing stents in some patients with cardiovascular disease.
Read Original Article>>

October 2, 2009

Nanotechnology + 35 years = immortality?

Filed under: Science, Technology — Tags: , , , , — David Kirkpatrick @ 1:40 pm

Maybe so according to futurist Ray Kurzweil. I’m a fan of the futurist and often blog on bits from the KurzweilAI.net daily newsletter. His take on these topics is almost always very interesting, and you know a large amount of thought and knowledge have been brought to bear on the subject.

From the link:

In 30 or 40 years, we’ll have microscopic machines traveling through our bodies, repairing damaged cells and organs, effectively wiping out diseases. The nanotechnology will also be used to back up our memories and personalities.

In an interview with Computerworld , author and futurist Ray Kurzweil said that anyone alive come 2040 or 2050 could be close to immortal. The quickening advance of nanotechnology means that the human condition will shift into more of acollaboration of man and machine , as nanobots flow through human blood streams and eventually even replace biological blood, he added.

That may sound like something out of a sci-fi movie, but Kurzweil, a member of the Inventor’s Hall of Fame and a recipient of the National Medal of Technology, says that research well underway today is leading to a time when a combination of nanotechnology and biotechnology will wipe out cancer, Alzheimer’s disease , obesity and diabetes .

It’ll also be a time when humans will augment their natural cognitive powers and add years to their lives, Kurzweil said.

“It’s radical life extension,” Kurzweil said . “The full realization of nanobots will basically eliminate biological disease and aging. I think we’ll see widespread use in 20 years of [nanotech] devices that perform certain functions for us. In 30 or 40 years, we will overcome disease and aging. The nanobots will scout out organs and cells that need repairs and simply fix them. It will lead to profound extensions of our health and longevity.”

Older Posts »